BillionToOne Closes $55M Series B Funding

12 Jul, 2021

BillionToOne Closes $55M Series B Funding
Photo by JOHN TOWNER on Unsplash

– BillionToOne, Inc. from Menlo Park develops molecular diagnostics company.
– The company closed a $55m Series B funding round.
– The round was led by existing investor Hummingbird Ventures and incoming investor Four Rivers Group with participation from Neotribe Ventures, Norwest Venture Partners, Y Combinator, and Libertus Capital.
– The new investment will be used to expand the company’s clinical lab and commercial team nationwide.

Biotechnology Genetics Health Care Health Diagnostics Medical North America
Crunchbase icon

Content report

The following text will be sent to our editors: